勃林格殷格翰凭借中期阶段势头推进关键肾脏疾病试验
Boehringer channels midstage momentum into pivotal kidney disease trial
生命科学资讯
生物技术与制药领域的最新动态
勃林格殷格翰推进罕见肾病药物进入三期试验，尽管中期数据令人困惑。
Boehringer Ingelheim takes rare kidney disease drug to Phase 3 despite puzzling mid-stage data
Lonza预计2025年强劲增长后，2026年将保持稳定增长——Finimize
Lonza Sees Steady 2026 Growth After A Strong 2025 - Finimize
Thermo Scientific DXR3 SmartRaman+ 光谱仪用于在线检测 - 医学新闻
Thermo Scientific’s DXR3 SmartRaman+ Spectrometer for at-line testing - News-Medical
赛默飞世尔科技DXR3 SmartRaman+光谱仪用于质量控制 - AZoM
Thermo Scientific’s DXR3 SmartRaman+ Spectrometer for Quality Control - AZoM
ChIP测序市场即将迎来繁荣 |• Illumina • Thermo Fisher Scientific • BGI - openPR.com
ChIP-Sequencing Market Is Going to Boom |• Illumina • Thermo Fisher Scientific • BGI - openPR.com
瑞士龙沙集团接近出售其胶囊与健康配料业务——路透社
Switzerland's Lonza edges closer to sale of its capsule and health ingredients business - Reuters
龙沙集团在2025年实现强劲盈利增长——医药通讯
Lonza delivers strong profitable growth in 2025 - The Pharma Letter
Devyser与Illumina达成战略供应协议，提供测序仪器及产品 - TradingView
Devyser enters Strategic Supply Agreement with Illumina to offer sequencing instruments and products - TradingView
合同制药商龙沙预测2026年销售增长将放缓——wkzo.com
Contract drug manufacturer Lonza forecasts slower sales growth for 2026 - wkzo.com
龙沙集团预测核心CDMO业务至2026年销售额将增长11-12% - MSN
Lonza forecasts 2026 sales growth of 11-12% for core CDMO business - MSN
龙沙集团销售额因新合同势头增长——《华尔街日报》
Lonza Sales Grow on New Contract Momentum - The Wall Street Journal
龙沙集团销售额因新合约势头增长——《华尔街日报》
Lonza Sales Grow on New Contract Momentum - The Wall Street Journal
龙沙集团预测核心CDMO业务2026年销售额增长11-12%——全球银行与金融评论
Lonza forecasts 2026 sales growth of 11-12% for core CDMO business - Global Banking & Finance Review
龙沙集团2025财年实现强劲盈利增长，并顺利完成瓦卡维尔工厂整合 - TradingView
Lonza Delivers Strong Profitable Growth in Full-Year 2025 and Successfully Completes Vacaville Site Integration - TradingView
Thermo Fisher Scientific (TMO) 股价近期上涨后估值评估 - 雅虎财经
Thermo Fisher Scientific (TMO) Valuation Check After Recent Share Price Momentum - Yahoo Finance
诺和诺德业务发展主管在200场摩根大通会议中寻找下一个Metsera。
With 200 JPM meetings, Novo Nordisk BD head searches for the next Metsera
执行资源塑造语言可预测性在成年期的影响
Executive resources shape the impact of language predictability across the adult lifespan
肥大细胞在结核病中促进病理发展与易感性
Mast cells promote pathology and susceptibility in tuberculosis
基于2020年以来流行事件的高致病性禽流感H5N1和H5Nx全球风险分布图
Global risk mapping of highly pathogenic avian influenza H5N1 and H5Nx in the light of epidemic episodes occurring from 2020 onwards